scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
3.240
-0.040 (-1.22%)
Jan 21, 2025, 4:00 PM EST - Market closed
scPharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for scPharmaceuticals stock have an average target of 15, with a low estimate of 12 and a high estimate of 18. The average target predicts an increase of 362.96% from the current stock price of 3.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 14, 2024.
Analyst Ratings
The average analyst rating for SCPH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +455.56% | Nov 14, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +270.37% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +455.56% | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +455.56% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +455.56% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
37.06M
from 13.59M
Increased by 172.64%
Revenue Next Year
85.77M
from 37.06M
Increased by 131.43%
EPS This Year
-1.98
from -1.42
EPS Next Year
-0.99
from -1.98
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 38.9M | 101.2M | 213.9M | |||
| Avg | 37.1M | 85.8M | 170.7M | |||
| Low | 35.2M | 72.5M | 115.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 185.8% | 173.1% | 149.4% | |||
| Avg | 172.6% | 131.4% | 99.0% | |||
| Low | 158.8% | 95.7% | 34.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.90 | -0.55 | 1.25 | |||
| Avg | -1.98 | -0.99 | 0.27 | |||
| Low | -2.00 | -1.27 | -0.28 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.